BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34148050)

  • 1. Antisynthetase Syndrome Masquerading as Hypersensitivity Pneumonitis.
    Tzilas V; Sfikakis PP; Bouros D
    Respiration; 2021; 100(11):1105-1113. PubMed ID: 34148050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Utility of Bronchoalveolar Lavage Lymphocytosis in Patients with Interstitial Lung Diseases.
    Tzilas V; Digalaki A; Bouros E; Avdoula E; Tzouvelekis A; Bouros D
    Respiration; 2023; 102(11):944-947. PubMed ID: 37866357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.
    Barratt SL; Adamali HH; Cotton C; Mulhearn B; Iftikhar H; Pauling JD; Spencer L; Adamali HI; Gunawardena H
    BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33419741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Pulmonary Manifestations in Antisynthetase Syndrome.
    Ghanbar MI; Danoff SK
    Semin Respir Crit Care Med; 2024 Jun; 45(3):365-385. PubMed ID: 38710221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interstitial lung disease revisited].
    Jiang HD; Chen B
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(20):1453-1457. PubMed ID: 34044517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrilobular Fibrosis in Fibrotic (Chronic) Hypersensitivity Pneumonitis, Usual Interstitial Pneumonia, and Connective Tissue Disease-Associated Interstitial Lung Disease.
    Churg A
    Arch Pathol Lab Med; 2020 Dec; 144(12):1509-1516. PubMed ID: 32233994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic Separation of Chronic Hypersensitivity Pneumonitis From Fibrotic Connective Tissue Disease-associated Interstitial Lung Disease.
    Churg A; Wright JL; Ryerson CJ
    Am J Surg Pathol; 2017 Oct; 41(10):1403-1409. PubMed ID: 28614213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings.
    Wu W; Collins BF; Gardner GC; Hippe DS; Ho LA; Raghu G; Pipavath SNJ
    Eur Radiol; 2023 Jul; 33(7):4746-4757. PubMed ID: 36786906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative incidence of interstitial lung diseases in Brazil.
    Matias SLK; Pereira CAC; Soares MR; Fernandes FCV; Moreira MAC; Baptista FMA; Prata TA; Cordeiro Junior G; Mancuzo EV
    J Bras Pneumol; 2024; 50(1):e20230232. PubMed ID: 38536981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical manifestations and treatment of antisynthetase syndrome.
    Marco JL; Collins BF
    Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101503. PubMed ID: 32284267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.
    Adegunsoye A; Oldham JM; Demchuk C; Montner S; Vij R; Strek ME
    Respir Med; 2016 May; 114():53-60. PubMed ID: 27109811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrotic hypersensitivity pneumonia: focus on pathology-relevant aspects of the new ATS/JRS/ALAT clinical guideline for the diagnosis of hypersensitivity pneumonia in adults].
    Berezowska S
    Pathologe; 2021 Feb; 42(1):48-54. PubMed ID: 33355704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antigen identification on transplant free survival in interstitial lung disease.
    Kypreos M; Batra K; Glazer CS; Adams TN
    BMC Pulm Med; 2023 Oct; 23(1):404. PubMed ID: 37880637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypersensitivity Pneumonitis: An update].
    Chauvin P; Kerjouan M; Jégo P; Jouneau S; Lescoat A
    Rev Med Interne; 2021 Nov; 42(11):772-780. PubMed ID: 33941410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases.
    Moll SA; Platenburg MGJP; Platteel ACM; Vorselaars ADM; Janssen Bonàs M; Kraaijvanger R; Roodenburg-Benschop C; Meek B; van Moorsel CHM; Grutters JC
    PLoS One; 2022; 17(11):e0277007. PubMed ID: 36327336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis, course and management of hypersensitivity pneumonitis.
    Hamblin M; Prosch H; Vašáková M
    Eur Respir Rev; 2022 Mar; 31(163):. PubMed ID: 35140104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease.
    Moll SA; Platenburg MGJP; Platteel ACM; Vorselaars ADM; Janssen Bonàs M; Roodenburg-Benschop C; Meek B; van Moorsel CHM; Grutters JC
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32933078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.